EP*~'{txݝ ^Uuτb&0!`E2!&aHF+a !CFX1֖`Gj#Z[\k`0YV+g|$0ˏ9}>{>BDSBx?&1QҮ^ !k_tfMa!lRLBxFOts W:puX '_>E`B*/џ>awJ?>w٠,L N `@>"@?0%,ѾMaj."fT}ݽ`n)w\>ۛC7(=1<%{p\+iͭg(.`69Tt{*ee*Ӗ$}h)Q)lI}L1`M`0K޵",,VN[Vnk/z{'S[77?A|vݢEwۺ}}f<>o׼W[/!|G,8#+v#|NyR`¯7~{}r~} h}|^yK† 7J9(ݣo$sDq]䛡OV\}۞h߷ Co*vh:6kSLxb~MWVX`~̩QSJzIkSxL17m?~akntۚZoyNG(T>pӶu'T_|va[1͝4176'Ҙ=$;TŪC?>Uڴ. Ґb͚v|Ub5"R!"v_\[j_ώ0/1k2(9_#奘FydK1 _ og1_7+Χr#vZk%<'ZSmu`^k=aVt-Dů!bT4QҎ5m\o>i>3c5Ou^?evO,5~/WJqyj:X;UftRD(>G R8+ޜ,{+WL:yJrO?C')'/JLeW+cf߈`3SLx$.IL1&13ń7L"`ڷ9uyBI.=:汲o6&߇;CǙ}OiQ gIO=43t ӭVLhاm+hac?g :k2I:3'/]3@ g3Qg 9VƆ}Sg!\4=C@Eg.ڧ Uƒ2xk_8B:DriT< eiqMyأҲ|:>d?|GyuI6gʃ3H2#<&0KܢW-őr|O+4?T禫韩?yVa\'Ԉ=sj+xt4ak<&byO߰/ؿ|'uM2]sBk|OПI^f-J冇W+"|7`Ō70YRLxd(ń7L0YRLx;ޛ P)&<0uux3{xyu>9T+l|KEykΉaNe>{>[I Lx`#|JxfIz/RF$1C̔Xq ,1N4O= ].11}O q)#F48s{V\q'Gk42]"2FzP=ieo 㹩A|Oe%* ,P_1I徵Gϣ7ƽZMhVU&):Svt1sN͜ߕϮ4o#;;Uweiq8Pys 㯋CpnΞ-QLD||h׉8 C2=I&]L- o p;k T^F7'E&d&BNhc}BVxڤvu:vpv,]Y>-E%t1:.Om2|iCl׮gg 4H-(A)D >g9^d=N^ W:5C)1I:S~Fuk^:-gE}Nxgۦ8v]~Og|] kBy@DCVHYu'feq=1]y}!ҎAx7hLX-kW}e``G],_#7Gţǟ;IC A)~kżY]LgjXooz[c;ɌԠz5w?TaW_=zb6Wx89Y;uG)NJOQynYW⋟ˢ5#>:9;g;ǯ?z,<< UqX~-iJZk0[D˲ Y~eEd=GweŞQ!͐KokS2χJ[ן?Jedo,Zbٮe]yh\Z͏(g3gQxnuq_yj]AJEqH;*h ds_'_ m5ÇhYOE7>vpqm3Y`<*hȵmsVX=Yu:}]%^UkT?hdB4yS!u.3[\L:SEzX 6]kےbG+[3rx|uŮƃR_)zXcfc']ػ[q;roo7ٝ">2C&i$_e>%acvK W7c^|>;wG6O}Xoy4ʱP3t>BS޿B-a,Nm=Y¶'_g[y̯mʷVpp|RFU 'E,$6rH ,"Qk2uR燌2XiOI313c?bS;vdijlS)_˸Yw,XRoߗЛ[ɄMdsy,ԲE/4._Ṁސ !{Zi7jijt^$NvRrRRcaE::^giRH=[uiUo%wZG߭(~XAul&drV,K|\+Z;W*ޠfm\WЦxzmUPW|c V@hnš`:yϙqi[6@>70Sm;DUp%fc=+eXLtbWvTW\b'3ȍzH|tIiuzcz]vCw e,Bw]utשcEEKv>fd.تSuzl?-^lM2"'%׽Jwa.{{Y̡(H"Fef(/F9be A-_E.",_RR-U,[gy}[PMW\k%,1ڧ"f?󁹄r-uU%ceRkY?/Ab c^F11yEIeb |CTNpAX9>t>Q|JP&>@yXd<_Nyȗz?UB~kd.%A{*䁇<k+`ĊuL'm0,C4`d˺`ؤwȷRLl&1ΑeVnEqvͯp1x_tI~sp:7M\zy2)u`;<7)eېvBWտC5{ziؾo.lwp!ĎWyx,N뮖]Zw8yzusHyOltAlMuQdgPd)tm!{_) {# >O /ń&u2._6ۢ^

am̧fd[+YyTmeb(>sQ0:ީC˪y /*Gׄ|T?+`ݦ{p܎b[iӖ5Eud]_.yϷKN)[6Bnx-k~NJ Tb}\ x`EmtE`?P[QO0/Wb^#2{eyߵ̿,SogeO}Hݜ9<ſM>e}R5*),?} +txyS*?<0N׋7띙e-DoP&|sT=u^CnߊY'"O_yXL8BG>#{p&VOz]ݴ^2koVcuNyXW&Gr^r!gEXyzIQb/߁̍f̑LL1zl1a3kL9y#cl63iK%aM!ԗc6f}2O梙eNa܇QԸɬ76lnC8_1ww"3~52sN+:@+*6Oɩ.+ՄTxH1 DccQ+I1 1Q1mm!yQAhswvw,co;=fνMsnʹ _r~ iq.z4\ȹ{UoT++*xQwG_s.'p3w[얹H_"[eyV5ʏL(4O7#: u 8߽AY"rӕt*+MF/A"ZqGGm|5*Y_n]{ܝ&Y; _?s>2FT'=1};j}_e׆7:jWEr٘eh`U o͍ՓZ= 䴬^ؕe7Vur@vG)orzJu|jC/=]/w w'[-S#"3QxJbNmL [f=Ty7÷O}0μ>ݙ16Yzp qn"a%",Ǩ@]ZXa5-ONWJ,QJdr6?QЦB3\=}-Ι5?L⹮Ezw%qޒɐ:bNo\dA< trMOU5ԉegڄvވ켭jvΆ#hќ=վ?vOeg};_7|WUSb:Fk?Lt5Ao~Fz< k7vIC65vFIvsnԎa<.o.]了Hw3Nvi5(T;#U5$"D2OsoD'âEDdg Ɂ1c /w ,f,e`+ NTi͝= K_J8l{4x3"TJq:/I|gT*1Wdm )7kmLؔXd&(y z3YF}F,7?Xb7d?ljoW"Gou!zC6?вѸٯY=cZ+{H-bHu}ZG^J^NzS}FZ)Y.Wt?"$=e]딦E'~ DMڃDz MOu.U9gMIirڴ8:#*͏8Kdu;+އi+yKQ} )e''P|zOZQў2Rʸ~ɳ?o &`5!;`/g;OcaʰĂʼn-}b,w=/ɓVԼE>;G\HuhN4KE'ʵ\oǼ[rpLЌ3`vfL % ;v~xGrjw0>,g^+I޳SoQlMᅘd"BsF|LYjoᙐg8b͟ X%f;q>!$b(rnWľޢTIeƾOt<ѓ}r}Gۦ<6$Q CT/OM׌s+dnb;֥ fqzySi%*d:ea}ʐB"wK̒/}=sO(UKYn>+I&9 s49i3E+WIk Ykx"fx/cu)aĻΤ!f!Rl@*eCE6Y]|S|2,4>J_ @ }Xvf^Q#[)|:Su۪e\^Γ+oZ>RkJyo(OKUG=a;߼kU֯|~e?Ϗ.ݎZ9߿ :w7.ӱL8N}KdԹdi|_O$V)=uZݼrOKaXCE|xE#M5 +&'Ew^O|?G)< ɗ#WloB|Չ,aCoxE~I?kTY 6}_Z֊l>6-,ޡrẖy7ǼQ]73/D|c{c6]*ۻ+:acl>9pNZ"6% l~A͋Gg-Ÿcs{I5{%\#K36dY6ہ>om6ecӋMش~$fncie.j 7Dyؔ\Yw/ }m&^ϳ[|Ւ#^YB2_ ݿH,/v=E#;_+%{4{EV'펭ml58<6oFB=H.Ӳ]Oؽ~$Cg(Jr o3Sܩ}"XoMK1Lzy漫-HN$ϥ|#D㏐7yl G3N7s|k-_ΐ^1G¡4SuyVo;j?euSnӷ^5J[5zǸg5RΕ_P~[|O7`lC)<_--"S`~x#g~(I "_02XE;|x" O&d͊6,JN:ϙ+{f#@AID\A&30"- eWT'|#EEdQw=y>//[1m>Wrtz6 u:2Z^+W(:wh޼QW;j/SyP[2\[oP W:{]rDMLj@&S+\{'>;Cund7=y{GD/ Ɖ|;p.Kwo^+v\Ètxtg_.sn}U;؆%w|}67okCo:V+~R]w[N;536ͳƉ&ើ,;tH[w_fCEpCLF[;4?~uE< 1c}E=FiO ^ވ^<eۙs{z[G+{]mxg湚CLx`NU<_B=3u}Oǹ;9o*ר1\qdxd(Z_15Q_25ɯBA?ɷ +{/'$"O~;l/ge4 ʸhoWH={n_dO[+7}| )'cW/Ȼ"q7~MLI|H܌qS7E#o! 0I!&<0wmu}Ĉ7ﭰ'ߛY)}ͺ,yE yɓ:\ko[+oh&r_2?x1po2lLӋ$/!c<ږJi|N.kiY"d2~Gm[0BLx`^6y2,tysyW_9<Ms6|ڦV f-+BRʉk b\-bz?~\S̳G6Sbo ̗ͯW/hY?úa>О)0Ld|2xx *fؾ)0đ7,|SJTbӲCb.ԋgt1ڿgE{O.4YzFJVoP/6gƷaazQZFa79,ߨo[ z\tloV6 r]vLEs]]}ܹ~6^)7XgcdL7y|R%yR ϟsl7'6{ykd~ d,.W|"?cd<a^cW#ڙ_|0icmLᐇb*.Q:NsNN!ST N~R,?.1cEFl _K>fC.?c!~2g<¼uב- u =7?Ev"kuz^>J*Ewrl-{Jmakplzj<7<0]oRoP8m؟p5^I)OY;_%:$) |yx$e{KogGuv͟rO;ݓR$2lRp߿?rC֗߷G]xdml&/,˶WS_O\ʦze^TZJ~W/j%[Xµې}dU u8:oc[zVקlZ<,L]b}}ݠ6#خ=g#>>1+YG|K|ki1E"_} uG{3[ &}=z^\jIzc99Rla^_@9~m#0Kq ac-͊_ܱ*١K-ή8-?/Į;_ Y?<}iwt_VHt?d {݋G쎀L~gby+O5uO<[1xG2/?|Ol6p eaoc'n/"Eo&Ky}g뺭A~lY=/O;R1l}3,/ft<9~<%Q_/qK"./-"U-I&MjCK!&<0S<&^g^'??] ;`v<.\^9#J{k(kϚ(rۡ*G~N?̷_YP> LoځEYu/pCِn;" o@bOeM+eyU$&jALE#bb`>C'M{dJ%S>N֯؛[x:(q3{zxa{uGf~h>i~ϊkϛZ#i Diabetes > Liver disease > A stroke > A heart attack > An angioplasty > By-pass surgery > A stent implant  Have not been told by a doctor that they have “ very high ” cholesterol  Do not have a cholesterol level over 240  Not currently taking prescription medications to lower their cholesterol Further, respondents fit into one of the following risk categories: Known Moderate Risk Respondents: Told by a doctor that they have moderate or borderline high cholesterol or that their cholesterol number is between 180-240. Potential Risk Respondents: Not explicitly told by a doctor that they have moderate, borderline, or high cholesterol and are not aware that they have a cholesterol level of 180 or higher. Must also meet at least two of the following risk criteria:  Have a family history of premature heart disease (heart attack or angina in father or brother before age 55 or in mother or sister before age 65)  Smoke cigarettes  Have high blood pressure or are currently taking high blood pressure medication  Have HDL or good cholesterol lower than it should be (below 40)  Are overweight or obese (BMI of 25 or higher)  Are males age 45 or older or females age 55 or older xWMhTW=ofҘ(FA()&YXQDBc'8*b)\.]]VQ &$9k&Cg {{> NJu=-46فBߔ\Iw̷? FBςboZzE8+ˉD5\wܩ b xǓApObj1jqui<bџcMïo{CZX"4<`468p"8[r)ÂnM`91D!CcQ L,K) ڷ^ڗ[Pm|+mۈFʭ:ʊLl/|ȟoɻy=;oׁkUW붐+rcڈvڷS;O6$oϡ_BDnӓfV7mSL c,qLvWh_NwF5Wqψs#)l Lj^_"jh7s%ډaw[ik4̑{2tN{@}\?ڇ-"b6o"4S~P9^O]"u7=6U qn^"Tc5YE<_"9;ȺoJ)e p Szsjji-8-}g7S}-+&So&+־6/_w'U"}mV\e}''>;O޻bK=rٵ2}?kw~:P@ *tЁo+uMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:49  Ch(  rCzC(160M2fM/C1FIj|{Xx՝ ^Uuo 1Ca w!Z* B$@L`L b2@&&>V Z>Vk V\kQiABx,|Եw3۹63H?89}{efIYvݳla g`i~(>&eg">K&9IT|y`9]'NekU%ٺ,WZտ|f(el[#Ӵ==l6엶Xi/%쩍[O=7{ֶA:uêŒVEu3e{/E..lg+lqvʖRم_umٽguۦk5mm~r֠i:n'<ܽkmc[K{~NZVv͕jXLjwٳhG7u]f=enm\_ ő1DEb<\j#ߞ?ىl˶kCˋ+mVÍ:: VDe#9tX0a"I-Tl/x@̵8d HI0GU`MݳO>hַE5Ϧn~sc1J#s`巕cYdob*Nb.'Ld03Mcrś 62bw_MȨv6Ձ[[lf9'(~,b\<}N^u>ׇ@Uq{N|P~jL7}j]{#zƷKUvUGsbZ,qc~> SSM򬾗Ǯ;cms亃k+}vqutқ5TPuGu9`Óhn/dgN"gt=ݟ=>7>9|L?E_8 ˲'e=7}{zLԏ;TFvP%Ddghg},w\vd$+g\7-NKԁNä :U2t:xxw+?;1`GS;I$N,eڛ+_|ܟ~|IfثDi;9m6{3'l¶%; (%ݱ6 pSXh=ZzPEOgy!ϵ?$|YaY1;SKFFɭ6?6; 71r$\akD=b*WSw_3u,ǩh(>J܏J D[|6_~{5C;]e߷c_fj.|'҉>iw>5]vFUާd;LQ7>v,n7tc33x{=J(=n lGvh1#صy]_x)OyW?/:'o|kRE[VN[~ [I-m2lj:Nܓ9qYta'EYȼX&el9Nu<\ iFuo2ڠKwcΕdi/R'3N0:`4&mk|mSubv.Mԏ#暴1o?.qcvvjo8B7u=ڶ\긫dԡc{1ߠsR)6 /sX_VuSBkyɇ-^mƗkU9}꯷ntT}oS@Fk~ʨ-׈-x&(Q鍞CJb ThIgKv|R]]ll򟩮ʰ^dQ?O,?\3dl6d=y+Bo rk,ڮ1'bܽ_>ʚa>p:eo#i,-]wU;f*sGQ}(Gy{m%#6-VmMۆŅ>2/E_2fˌJQS6G9636V1u6M\姞l63 6}qGxkl,j/2v)AXT4-Wu5!1/쭊|d{v#šٟk"\s쑮^Od0Mq`@7F3\3UZ%Rebq6-('YU"5h`6X0k"#cWEo"\>[5Ld|X~Daz=)z>]Da'],DOWNלzu5:7௳UWgf.m07/<NOiYmCR;hK}ƶOai۱ַ~y,{Ăyu Lc1H=GAWzM~XuEՕgƦMb+Duy]ŷ=YTח%]o{&ηa۞oGt(~tW*Wr>]tNu0mDa>0h{& o ^{HWKL;̧{ҶŏX!~o{=EK1oķ=߆ɷggGo//\|sEu L|;ܚ8ŷ=YTW0mķ#:߆o{&aU߾^Tη0mķ#LgZ/j`j86^ fsh槹#>-ۚE3%&~,\Lf'im"&~}D#c߆#u"? &,ryEյGիĘs EZ|9q=Yi?m5Ld0 m,. 4Ȣ:]yX0^DaIW%_kL{=EPI 5Ldo#1[,zB,] Yy&4Y=JJ:e\/jre-T0E#\L:ƺg"ɸmVN/fmo'n7+4v]G2 6k|^y{Y;2p(V&#m5=Oev.9=+0>(o9LW۰d{yd~lRlyg2iqd6s,E5O.-K0Y,¬Y0Cx&1+̥!2O3El5'eȢ2_!%nh)k[])LebLg"0sq-n]&5=LФ'븸`Zŧ50%߱HNf~"Y=6& Da'sg"0s&j0_x&& Daq& Da'cWIOO1?=VW ?Ldf.a~T~`wM~ʳuoOX:KÒ1.vڪ)mٶ)'qץ)+:,johwl0y"#_UOޱg"0s17L޿E^Oޱ9g"0cÄ`,QNlsKmahҠvĭTBrv-`Y{XNwԁ:5a[; `|Mc郒5r\#w٬.ڏ-/%q %n0g8xrɑ1Xc`xΧ cX9)%[` Y/`W[GJyRqulu~~G^tO] 4dMg9kaWdM3L8yVl4Ski4dMg&c$50F4Gq/]X|r ÑycrE*k@5Y'x5ͫ>CсjM3`Mk*PRR*baq$&NԚfl{BlL?Wkk K4癠糮x62Si}ԅM>H(/ Em`*k?nZ Ldf.=6*a3&L~3t/}5s|Klk@{̕5Ld2꿦x*Aܥߕ8>߱xF[_)x c1)kNI}Z]4Oe|S? Xߘ0籹5`@F백T{i/_g^ԆK- ؚo ,o@e=:MYJ巠StHwd*dlZ~jyd xՖgѷN9k8T<3dgwiێCαr9r]x ǎ5x؇k;4;sCꆁư(CfL[7OgN+:9ϷZǙmr8+RJ'hq+5ԏ3du\8^wFߓ_&W@|iCG!/a ۠k&Gf1["Xef'hj%b*W2WHeا2VUWo)~rezRzH9ׅ:5u#):]x˫ )o}-ضzi7]N*kbmua5S~sVcg]]fOu"k^S]*<ϙ:_2W~#Seا؄N:XFFݜT7)~QEů(}|(ZT-!}Oz` w^d#ick/WCz*:Ť3dZXVG$d6} }ަ1xoSYS_mb!5'kaWPN٬!.{YC߯!bd 1LMvl"üXCmWtU8S{Xg>a܏SY=lܵ[C 5Ğs~Kt Ljyur/<9ZCLfk c {[ zkmv]m9#M} cFS686ƴYY糎w6?S =hc聍m'z 1:y xm,jBϱ/\ ݈e +T4-WSc([ ]5L1D] ~s;Q(x=ɖjȽ,W~sL1Y;@&Ųuŝ=S}ܘ'bF9>dszJ2V}ONU6%vl|#7طz?W:|&gq9ǚ.VKu)W;X:%`k"cġUy"\.eg+K,&2Ӧ1}g;:,ktE0Eũ-"\^%29%z\Y˽ݩ]_ a'=YKJM:XUz&2&=(X˲Z$cZ|)eWq? .+#7(3MWoHV7+Acԏ$.3EmLa<Yyx\/lj/,;a"0ODag}?a"0?O̷hy=EyрX蹶,j\o\YK},51}}J x"\ASaP7( &z4ydgo$De$PT-oSި]-78_Rž\Vc"Y$ca8)1s(8sLYL㣳dwϚ=od>ݤɼuy0a"iůCʺ<ȢRѕy L戞,뜚cJ,ku}Ăx YD׺|"qO"o*qŭ@:T(k[x@ܚT7&-Dab.Pb,sM0ϗx&2\s"|-𧻓+NwX{ |>ٖJEl">Ȉ e[M92dƱddY]OYC)] b[b-h=~i1 &13I0;Ť5~N܁KL\dQ]}LILLbRD95G܁KL\dQ]}LILLbRD׺{l\b"U)I/ĤӔ+kISY*6Ɖ;0I,[v ELbYk,>\c56Q*] W;_,F[|NysZ<;bm幎4d}+[m7fr֊I{?k[ͪUޑĴt}2)Cyӕ~dM&|t>%>E''WW$_p,0I|:&fC~G\dQ]I} Ld&ƀCɻDa1:e\qJ8qZM)0_bLg"0s1(au0/ sDMzn-z-;?0EӳSpJ[6&fMnd;}x$tC;I>IlD bLbg`v s~.s Q]}lIlLbCDz k}fv2\dQ] &s/dy"+S<YTNS|آX  WݖU5M~7$ٱ7oO[HoCnU*6z2iғL]hFczxCOKfexHѮ O]h}.stl`¼,|1LK^Od&zV zna"0zO%^Od&z![y0Eޞ> L+y=E٣ԫSh;ߒ.)gndONcp Please select all that apply. [MULTIPLE RESPONSE] [RANDOMIZE] Known Potential Total Risk Risk 1 Seeing a doctor or other health care provider to monitor my cholesterol 8 13 2 2 Taking a prescription medication to lower my cholesterol - - - 3 Watching my diet to control or lower my cholesterol 32 49 15 4 Exercising to control or lower my cholesterol 29 45 13 5 Trying to lose weight to control or lower my cholesterol 28 44 11 6 Taking vitamins or supplements to control or lower my cholesterol 15 21 8 7 None of these (E) (ANCHOR) 47 23 74 9 Decline to answer (E) (ANCHOR) * 1 * xWMlTUA(Z7!4v"3BQfjDD"@B50х B@H(&2*jlwP&Py L‚s9{n9 @4$eJDNQDZ/3>כH;`R3JA 7M@a|Sx7qvb3:{mspOOg/bxY|d K -]5ڐVm??AN~k{ i)[P7w ÝI+ #<2.r.cŇi/hۗxEG䫱vu4ux|;_ztM Ͻ/~jrU)~HhzO NK7/;d cW8ϸn&FE5hidT3wb||ofPB)oxkɻHA-5t*7TmQj&!qGbhMbgkYysx<?1ud``z3h#Z }g0k_r Ż\/#~$vQى-x}|" z!e>;)Qq=B#T-'O5M6aaث_✥=|}(Wq>Cp4Z:c#Vq~Yo!Q=1ܹWp0K&ao{y)[\'sA6n/s٩/ç;PU}ż>Lr.2!\%&<,m|OQx7ԍ;#xy*B>'qr!we yk'&O~$~Bwrs/ \qܱ5r+ 3];+uHkᄉ}RaOne^+8u6qW7r %*f!=GwYyI[?֪̠ȌV %([*%vԧy2#uΌQmQu}ua(]-g>AEc'f f f f 8T@ݏ-KMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:49  qXN f#qq(16 |2V|/q1Qw{x͝ _Uu_L7XLI&lqaHJþ2!&&&M$Jڊ~>b"`,`TJ@Mɻ373$7{9s˭Q^eE1oς}oQO<(tE#b&Q{J [=aTbEqIbUQ,*V_~PKkm[۶k{b8FWm+l#*6O?ۄZ۪[~}}}DzS$[뉭[iݲeqEYR,SۅTkK5u0V3SOFPh=*'0f o0v-FWǼN?ie¨xm~4RFu.v@gq턑9MS =W]eON)mnL׃t!;6S{6c<_ۥz)n@0WY=&\o)U\X`~<&g}elYj?^" dnGv?^;aM}POϓ?v)i*{#R# ?;_XFcjrlr|g^0{T7`(gRRb&o z2@TѴ X!b>ئ6~߮S?Ra^ՠ揽['$qN7yv[S|cG]ѼW5_XM4߹7sx;=ulv‡w}~?cϭ^xY#^LUSN=/=?#_|ۯ$tIqJ[Wa O(FL6\}N~F5*pgmNJzRMRs%;^LgeGqXqMx(&/Gzt =%p;Mퟮ38^hG׵k?[0 ]vP]aMbM1l DTx-s#EM(A>ч&0}fCpyȢuxPM7jq%CL!bUP㉌<\ڦ|fimPV"W %Jb2]p]XGpMwauuU z+ڣjι:JuyqdeFe7&q> .O&6k-4]T`o~y̱v,͹Xq,O!K[qk Cc,PpU*bĹM]U,[>ysډcaZSS!V\0wDs2b< ͗/w<_('Bk,[\Ys#_wi792͇hmorXsV'r٪a얲ÙV1Ѹ0cs9 }!/Me 3׿KhϩoЖߨ6oS_kxw ÿ́]Z*N.N:ࣿI>o=yE_5RXߩsSiy薮U.l:_8ZǚE_&Ngۈvڰٍ61<$gM#&cqd1V!mЖu(6<&\_^ ,0Ѐ ́܏|Im }O,zhbdOydŞͬF.2ugpg^7m-Ԧ nhW~?Oӽ ,.g~Ж>tlK>23kI*.8jO3Uْ;qv]okd"Lokt[-\Kx"^Y\V%/gTrmL_[,mctw)(d/ ъSl6Γv၍mx6E}b 6@kcj8w*qWա-󖿰``wu/4Liƒav+T{Ld9FsY0ߩňD&wdsuW)WT1jb-U&j9ej_EsILkXf贕*rjf>v՚a~۱]sU(cvr2lqMVV.z5v+ ,w7E r,T :*ggLGavDnmLk#]<&20擒1uw.ďh>wjﲧQc-m9Z"?Åt`uod|[m8Ա/y񱱜mϙ^m\`>3'w(c5@WKޙ?kD& _4cwA_rem&\р,kv\ *=Wd\'}a5DEkW!KEs{0{IpVlK6ĽE=Ľ$sΐzY.W]eq2q?!'T<վ}܃I{L>^kMl 0'}g}؞6l38W':ya5bXrϰ:[?U@mO¶b6'8[pRTjb_ ]zU_mLZ[S.6 +-Ј;)UVּcs%z1eF'E'Ӌ9 hf>;cQ?vn&z; pIdcZkeWxY[=FjMn6Bǥ iWLU ^ܣGséNxW`U^JWG5_O7Kk/<bQuP^ϽeC*lMc̏iG> N<'d0;Su<&20ߚV5e͐կd1Y3q-̮ eqrk0Y3xL y\ friA|o(DNuU\+pOT;3Tu `S<&RxfLd9sC~Is~0VO/<]ug߈7cG@C)/w^e7'cI76 p_C)lf\yF L [J|!}ɕx@5e_ Nױ)]nlzft)j|/ecU5c[\swjrIƁtgzz.7hgOa'|ŰzoQ&\96 ";W؝hݑ&ʀLdp/Ё\A}κK\hK*;Y>dq)%M Aޛk; |Ɗ~? 6aG9Py~MRL:0#0c"AwPsԒ!ɓ9lG/}T.|1 LSv^ p||>Ԯ"<? R0;( p5F[4woAy[ ˵<@q%U=|GX6;(lL,|ߙDt|m,3>@ۘ瞬G6X3'LR! ǃvƮG)<;#?6@k/to--*CB[-a34Y. &m\1b+Mws0?.r1 aLdmҽ]E.;yq Uj m%0,wt񉊧c"#iF7 [r]c_~d}IUm[[rmƱK\{Nrdm ?` c")=HV_#.\gŸk?i]}|_ |F#o7 ԴV>XquAkIoayu&LՀ,Œ>(xRkZhK[g=&|f)l_mL=&207_ᓫoolÆ66F\C1CUs!{Ld`S(Y<;Z;== s \[Z6\0s=&s.2yuG\\˜Ϲ`2zL߅ۧfX8v Lc(T8ӓs992Jw(*㺧Wd~~<_|BSTZƱ-Ѯ2yET KOqp>,fȃf{j3l@>|FF޽n-'cƞ>([Co~CUR?J1fO1bi}Z`*$y^ߑii}_O߿O &zLާNɆ}Z8t6p}\v~B\ާX5>u燶=Ѡ+W=>2~J 5 b ާ@k-mMUyo#<5\bSާK>-6}ZokާX=>̑TrM၍mx~u;6}Zod6(T{C@k(kEns/yk ˿O0S1`.\kxUD&k”,WfΘR )oY.2. TNhDÙߛ4UX9#saw yLdCGׁs;)=&20|ss7o1¦}@˛vҽ@lE.jU-k'C[J_rtt4_".$f=&Rx&g0J ľ$s0=OLbc"}0II`“q0_lD 'qfժZЖ浣T|IzL4:lv =wSƶJUA6gۦ±< W8ߞ3\;@)0ķDr0Kq &1Lϓ,>$=&`؀I|`shɳKTj C[ |;u!/b6K^] hn9*?QpI<)AnԁGsz=|gғTrua߯n_Wmן;d .qjlJ|GǠOn|/%;wܙ>}LDz|dR:llְR{߅PwVx&}Zϩy܏Ck8FqNgAmm`[dcG_qN3|g'?Ug~O7m3@*\B_;:*/N\LLwzjsW;򼓾xz,cLwzLw_c@x <]Et/\#_i1zމMyމy'6KAm]rmNGx|9kTr׀M၍m91ޙk@ibwz ˵P?Х#}.1 1GZ/g8G0` |y",q]Y5hV-Z<&20[ʶ${{[4jmMրq|GםC^e;O;:Y]`r[ L ڡ?WރwrEu۸^/,0c" \l0\gp}YW7v}"],kƪ]E iMH>jU-kTL'`O<&$sxľH|1`\/ޣB~ŝD&98rNՕ.oF.wBw0uq<.\>I>?<l0\y0YצߛD̃K>rW>WA>b?жL$`P|&cr0KaS!n>B̃ybc"szuwʢ\_r?b//-Vy~ru5 wQyu&L 7) Please select all that apply. [RANDOMIZE] [MULTIPLE RESPONSE] Known Potential Total Risk Risk 1 I have a family history of premature heart disease (heart attack or angina in father or brother before age 55 or in mother or sister before age 65). 15 13 17 2 I smoke cigarettes. 31 17 46 3 I have high blood pressure and/or I ’ m currently taking high blood pressure medication. 25 24 26 4 I have HDL, or good cholesterol, lower than it should be (below 40). 9 10 7 5 None of these (E) (ANCHOR) 39 52 26 9 Decline to answer (E) (ANCHOR) * 1 - BASE: RESPONDENTS THAT GAVE HEIGHT AND WEIGHT (Q340/3-8 AND Q341/0-11 AND Q345 > OR = 75) Q347 CLASSIFICATIONS BASED ON BMI (Does not appear on screen.) (Note: N=728) Known Potential Total Risk Risk 1 Underweight Q346 LESS THAN 18.5 1 2 * 2 Normal Q346 GREATER THAN OR EQUAL TO 18 20 15 18.5 AND Q346 LESS THAN 25.0 3 Overweight Q346 GREATER THAN OR EQUAL TO 25.0 43 44 42 AND Q346 LESS THAN 30.0 4 Obese Q346 GREATER THAN OR EQUAL TO 30.0 38 34 42 BASE: US RESIDENTS AGED 35+ AND WHO REFUSED WEIGHT/HEIGHT Q350 Are you at least 30 pounds over the ideal weight for your frame? (Note: N=2) Known Potential Total Risk Risk 1 Yes 100 100 1002 2 No - - - 3 Not sure - - - 9 Decline to answer - - - BASE: US RESIDENTS AGED 35+ Q353 How concerned are you about your cholesterol? Known Potential Total Risk Risk 1 Not at all concerned 33 18 50 2 Somewhat concerned 43 52 33 3 Concerned 19 23 15 4 Very concerned 3 3 2 5 Extremely concerned 2 4 - xX_lSUےk'YÈ0"бVuIfʘ9b1EMp8Ŀј"jbx jGޮӐpow}wν @{1D:?$#>GTOn߸^?w٫$2#4c0TED@þv w$^4c/}Fԟ𧏩6%B>{*Q{O Lp>Ezo0)\B6gQ'P;6yShcw1G#y\[梍>؉]8j3SD9blT._Mј'kN^7K=ǜC.6tSF&GT&5O=I.k[Z>, .W8u;]s(NLE5"MYBB"] հtxbk6!±.nm[SudN1Dz"/kc69+'~e$vw˵mZ q+p *0kEr'N|Cp8B>bxGux򁬿QcH-RDCfmTMvO/I俘62m4ۼGyU]"5lyd?; ."A{&w}˯ŏ]ڿ]NֱRk~UWϝb;틝wn p+0s\n V|Microsoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:49  ڤH} 'ʤҤ(162/1{vx͝ Vu )t4܏# ë+*<$k g= -!J[BxҦ!mUAY !5ov-a^RSMc]wPt6BsէW íaMX6Lieب|F+%mvct3dr[da-! *[.K|.kmWp|#_6jut+76d}m:oمa:3Yڮ;oHqѢqIk;|a@#w y}G[xф\6O ձ_Tlߜ5E\}̗8SکTMrV,uu¿MX`+D&c6WLϥ*_(Y%[f:qJ@j6<ۯm;ϫ{?Ѷl緿ւ/:B~{7ñ?"K);VL9TQ1Te  or :]= dA? &slbup}\!KM&lK»/z TkcN71ȼVcΒ>tc-]Cq}tՙߋu^>];NxB}煣;zdƖ[uwuCy:_&c3^g{d˴JG?|0!#-hҘNor36_~XI? *h3Bg`.ѵqHX5~=a1ۯBF[1N3k#ʟ`^zLd`j+1AsY°@3:/?r3HN?I؛c8[bχ`]AZ}ʣ#>.xi|dl8LmbE%D:>ŒcDޖRڮ]6W>Ƒ(L S$ڶmWm Ta܇_o-S[ɺ6O.>żTןoao~%yP9Od'*Y-٢!wb> s4 t0,#}Nl[ylK/;D?dƽ6gJ+=y(s)$2*+tcQ5k{NsD,5野딖 J0)*gdWf=k<s6V^2YR`T~ULҞwXg2삟;j8V%|_}"5Kt@/pkJA1~Lu?Qe\ k2KW fҕۻngDS|-!moOj5zn@f,Fjs|E%UcÍy\6T6~Z96owlY_e63?PqyIؘ1z`c;66 Kq_ƆZ|ee ?\Y)ʪ?R#%z-JkX_;Ld)~|JsH LƬ~$ZO| < X3.<^y:g=?9\)QfsD?pesSrvyLit._c> 3I߹sl5v'aZxdJ^aVѸzLtEku:#K˻[xKc%O+~-."Ku@ ]YSt}}V\uE녅sB`"KH8;`"K̄ٮTS%'Lb.Uઝʕ5pEYUg#0*,3U>Df؞xd ;TzE^?dgTqd1_y^gznTƏf:G?'-ၘo}D:S8ձ9_3N N–q9-w0bNNpoTL{\d[|JX`>P,9X`,3}o`"K8~TC\uE+5%]'cx^x(KfR?8Lc"K̄i1R`R|xLd`5UzgHC=3O\2[.p T[F%`%.S?sI ~_ x\dz.pI f xLId%`%.Idݩ˸\%*.tK=.(Qf0 `f4.k 0Q|xLd`5Uz~N2KJIk47a% U5ѴF0aJתAGT/{^`a<@Cȑ1ǰpq ׶VO("LC\Cۿ${anRb0 sZ,/X`3^Od).R0`3D"=yNg,=#ɻ,=͚.|eeQ1㊲؅c2%|;^}}w>};~urcrۗ[>ޗO{'M>QIco313_W286_VV ^:.rB/wʈl~LWءV߹vUî^` .ne5MfϾkӇJhJ6GƙҜ\9ڲglp~hg{u+a BXWV$996?.(y .R.AO]e{|Geʏy ê>|I25oMy}N wTքy9Y>qmTa$˵g S1uܙ+TZKb 2dı͡cq4<S~kQfk)7 ks;^H87|RyWKoB)m W*? Y݂d% eӕد.YYB5.der6z}~X|98zx$ΰ~؇z=AyHeKl:ĦR>qopKgop秡EY՘YүT:yů8>D)z}`c/}}`RTG[m/ULyLWLS~xtaj>eUxi}*4]J_+uگsa y[ K9[emm|پ6f6NY{><>{zkccR洅9~cay Kq_3]U 1!EXQ{Ϫݯ ~ %b7,36GXc4YfwJT7O)O y 6fƼ3yܻaJ}V~/l|jl&edc"S+mElN3͏MWe}Pq !aY T鋮w|^D =߄&<1}>pEkt)<ύRA}-{{J+;́?o&*cA xLd)0+1/+`D1ɳ`$cmf|Z_Ia{n4.1Y5Ǹsa)3yW~OYM4nnp^i;xZyӕ/,U׳&3,E׋؞d2~z+&1:do.qڮהJ?aHY?eUq\&1`fܮ>W f{gjBߔ!xQWve~ȓy6o@F]xbt&+:Uxځņ,`"K|tkdD "}=xLd)~}̗Y dc"K 9DJ5%]ي 9^Ԅ>/^-0})EM[*C*$a͍>@\ۅn(ޜUkn؅57oHJpʔVYG:_5ne*꒬߬%mF*۰\::J?)O6o6_y:NF MrVyC]~laL=ƌ{-c~>GJ,ՎS_O ~re?SlCM7\=Z>JiU͚%W[QL/&&k25TL& %ɀ)qr2k2Śן5TmMff`"KLmcaA[xV3ޱO9mXá%m Kg>G}b}gKf>|3Zg|OƎYץ=ީ^߹ЧS9:p~t`\s k8؂o d> =]QY#llLۜU;؀ojw}g6*PlXSN2ִM9c`ލx Kq_1Bzsː,ʚqY_B^S%Qۓ.Z / \x\d*7nFWr͠%lKk֬c Ezhw^dn2akޟ?V=&[O+5OݪE &1yjv2YO xLd)9L8c!)e&1L&1LoOxLD[lܗ ̍%R1OPj%{K+kKU֜qElYp% \J Cݳ=&20%'N*Nf*Y 7˿s*4*6iHu%M{ G8 aw5~-_Rmul`pD900ynR03a&&`-Dcg0'L  xLd)ޞO<&LlW)>llPVLcv#<.2pi+v.ņD&*e-dx:mu+6%f-9'ɻmĭYja`Y 3b<&L}q &q1̲m &zm da6F&ĭDJ5%]ҧEUN,?fq{qߴ%6%n=.2pi*scKl^ =`nc':^gj}`Y <&L1Lb<II{=`q0qI`z=c0{Ld)`2S1)=ȟ^ӕU9qm+EYX#*a%zo}_`.|ީC,,Page 5 of 19 BASE: ALL RESPONDENTS Q355 QUOTA GROUPS Known Potential Total Risk Risk 1 KNOWN MODERATE RISK MALES (QUOTA 178) 28 54 - 2 KNOWN MODERATE RISK FEMALES (Quota 178) 24 46 - 3 POTENTIAL RISK MALES (Quota 178) 27 - 57 4 POTENTIAL RISK FEMALES (Quota 178) 20 - 43 5 ALL OTHERS (Not qualified, jump to Q77) - - - BASE: US RESIDENTS AGED 35+ Q900 Are you of Hispanic origin, such as Latin American, Mexican, Puerto Rican, or Cuban?

Known Potential Total Risk Risk 1 Yes, of Hispanic origin 10 7 14 2 No, not of Hispanic origin 89 92 86 9 Decline to answer * 1 * BASE: US RESIDENTS AGED 35+ Q905 Do you consider yourself…? Known Potential Total Risk Risk 01 White 81 89 71 02 Black / African American 13 8 19 03 Asian or Pacific Islander 1 * 1 04 Native American or Alaskan native 1 * 1 05 Mixed racial background 2 1 2 06 Other race 2 1 4 94 Decline to answer 1 1 1 BxVMHTQ=(b2Zq@BF$W5bQ A`VjZdR$mʅȝ6ZD$EPU!ޝwFb;^4 8ƱU&NUp8wy EC+wQ!9چBT)ld0Yq0&w H40k V+„A4$,&"g:[Ff5C!˳Ϙr֑H{H)4Yq\k F-bD-ڳ;#ޅMBRVr5oej 9ӭ\v kx{Q/1I[܊! IƜ|Z?L^:1oG#F# 0)}9^A({\U~@FTjǿ@=~7U6Wz ,@ 7TMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:49  d nT\(16x2/j1)N{x՝ ^Eu  D z75$hg)$"Y!T|,$& AIPJVD*VT|D- ZOQ(mݹ}g'D7{ϙ3眙;m˲2,{Ҵl(E]YBO3gemS7fٱCŢSM{Bğ344[1cX6/[z\iiVWkDNGxLYGِ}c_CJDY:aӱ~G?mm۶WSϰi>]ȹ.luYVl4s`vCJڗQ^A q֩J1uGN}XQgd}hmXK^?'j]F@7?}'L%ٲi_mh +=^iN }Z{rh/1#CQRy-qt:nU^k )C`(/,0&c6KJ΅*'{Y.]:1*~ 6n 퇝4vw_1q ǟ>MS9ns{D߶/k,X>#&s+1?Tb%/H176qch֋܇WY?:4*_=B8SD7N%5^ļz Īki/+E9n1uT??Tn7c̾g0YbXF9G߅h7g=h'muh&M/;{N:Σ6p-?=5: 6(Xk:0I:[]egflK,8:fɼ5dg}yXW)?MIAsʲY*&gU-J4Xwʐ ͐$ώȦ1D#:@O+C DɂLW V&yjy%fQ^ffeU,ɢMt놜z4RzYdG/K*>`Gu}gd?T.b!4:V.+@# [+:[S|ٰ7d8Բ쉲aog(aoW*7dm\9O׭[iJ_T~ϔeukƿS?QbGws/4}Oݠ.*ח*2vݵP㵺b~YfFKY-/뭳ĻG̏SWSU,OT9S}W\U9ef 鯯-S:$;}Кe1+?@kMdMXTVwٮb}ose3&}΅>:^D\W\Y??o"%c(Px\S<[ö51_b/КbN|%to;fo%졮ꁒ!MJLS՝ {+5ģ϶Oh'Tg#E;Q\w&ekN{+wGsҋRVRl-^)5{TUohLu&wV(k՞_RT]<Ϫ)b ?doGwsںc5\1L (7e-ixmmM"8>v}e~1>u {nhMday.^gJN]Ǧ:[D`5-ّ2.2O2_+CJL&Nf%e]#czgL1Awl,sTLК><o.s딯W*i*[>QՅoܿOZb[ZB1gSDɵN|(Hv~2_nju),)N3$y9ػ4N[NhĞ>t>m˼̸'acSoa>cyy{(zKmoDVբyF[)шUXNߌDdMG~䄯-2ɹMj*oU6Eeu}$Zwf^Ip{V3eϨDՕEMvU遽DMx u[lta{ud<{1.PL\X}~y~NG:~ ^^#Ċ?~znQ;KCHJ5 WEEA7_ڡ\dmgZkZxv(=B=>Z}J9mB'764MDJ*Lc@uth͊u+g@ XͳRgDyWs_P=!zz*2 |Ÿ[o5c mic<>6m buơqm*/}*>/nL9s ֜Ɇ#չԖaK }%ڱ!Ee"V@#%lx4x^6?qu5l0|Ud)\xd}}*{?.[qcwN׽&r'I)*꟠?!ȵǮ :EXʵ% sgyvjso;[UM`g Ue2g]N-Ƕ]ڻNk><]n9\3F, td-94\+XvN?vpu@T0;7S;va`+J؎5O~EF)*r<,ޣbr}Gd`Ri !Vn"%<_ [f _Y`y%9Mu L fhΌ f]ۥ39XJmt_ozě>X!4dcR'BoG؟~ZS&>X`=&40>4E>b='"];#?HĚ\ αB]sF6YCkΦ+~((᧻ʴ@zE* ɘBgHǫrEuBB{d(W7C|YV7^O $CKwFSr_TfK:?X#皋h6gDӕO*c% *?G{Uc,\/Q5*Wkpvҗ*2V]~GnްlSL#SWj-|ԍǞcC܆cb416ԁ4#GHƈe^TA7Ǵ|Ȅ<)orhAs;|)wl=1ݖrc0Zv>ߡ-ixYAi }D~˱ccsw)lV%d@ OW:_ [\UX]1V9 SûW,Wv.RgzEx⭥Bqtw%cn[D$t|l; e֥q8 sn޴ŦqpN=ruS$hohԉܴTSf4sje_o"*7_,QUVg{?e6bي?- <{b9[41 <1>G8QF}ʌ9c6sLqM:mbC;h-myW.֘1vW4ƮMu.]+ީKMZ LZI!ںc_1z̺E_Z]M7=5K}뭫ʲ:}1}lʗ96U6؜Z.lkg;*zn4g26?Kމ֭X; 3',7+j)فRc3=;f{A+׶D9u^G綔K46P~FmL3irˀn|ˉ, =j"/1v®aWm7=#CS{/5aGO!æe,uZa;Qr88V:cWd٪+{ph:z=˞]ϑwTVw)QVUO\bX8tE< v@o]Qeơ-1+C]]>nGcuOY1˨K*p3d' ^`v+ s+0Y;V{rp_<+yUZsÖoeC:u~}_ŧH6@~ƾ]YVg ZaM&xW{$ CJ)&40M̷62V7:8";R>sDc,t(e^#0n.aboԧvҩ@oļhkb{tTКӞ{_yeuĞo{nK&G!ńjS'=,da)&W}k}d`X</kq^cعnK;.xnWmEglrXf*cŘ]P1fК6c+1] f.1I=l&,:Zb~A:Lu LQ[|p}Wj {~XCѣew'B&hM gw?,7f+ǦcgDZc|R\h«n!Lg^aسgW~MDpυutokx]z7Y@؏?Gu9up/nebߡ~>}y,xaZrhq]S?noԅ@mcee/qkusSmȆ}*)u6hTXņ{,jUT=ذ3ݺuUֺ Vb--?#%% :E_|Leq[S]#\mȅTwX&2NhC4ƌ􊱆X$j ;P_.mn.=BͼE M>0jK1}:߹D4f"1O`~-pu^ұpe[ƐYWBC.wsӌ}:>>vŘ.3_5;'KǤ鸊q8^8߲/;a㇯x~8,/}jʷW| R|ORٙ¬;Ln?ƎRYbxlYz9W-x'v,O+a O\1n߲hb+]{>O%/gJqO6Лmnj#>9c;s׵rfS8ލs(Sr1iSOԃzA|I7ևui]OZ/ޯ4lMlS]\}lmC褩^%^)}*[6@.yBa>pZU(P?7IVB㈻D%፤jvw {+lܶhǶ)|/io v۰yP2e?mb㺖rinbQ:.w\-3eԫjK-Ե_rLRPl){nB^?/KqplGdiKK_U?k'S\ŎDi ƾ)a]|e>Gy]xql IM\=nƍvy1&c (|_+&ʲ>W|' +q$;^W`{x<św};^óueޓ\wΰ؎8p,ъsbKLl˜܎rl-ݥ+}pO}mֺ 4=:]4bi cǂoT 8DebZf썰}&{j$؜l=}8K9eq]t8Ҏqq]{o^].؛CC勩Ρs M}ƕXL}cᴩIJC!>K^ab^&܇+x}!/t9ё{»A ^UZ-mG~^_u६ǨSu=J_0-T~h`:_mO-o"}e:iV_є ԌKVa55@-К9@6~?~5 "h`XϧsP^\ 2ϒ3g1qo$OϷ+A:7[e|Zn{ x +:[;cةn'f& "Kx-raC|ީDw}uTߦ'+亹\'*GZ#,0ZZSgJ勄l&4bgTH4{T~hMLy򫄅RLh`}-m':F/Udszmݳ޽=*&2sonO*“O=T~% c~WUBB/7=̙u#unڼT5z|4V:{D[S;gI_IysN)C$"^c9gYo| .%̗)&%RCm̉2_К\ϗ`2_̗d/eLq/ʚΗ`2_̗d tk2;DBk*+v֩&HR¿`)8Pyeu~h8>q '4%{UXr||N/s0x;L?|9i2r/)>0֬}ŗS\|//ʊ/Кʚ2r/7& .Bk*3$Aye'}u_N5υWWgN~4O3+dDV?ZS]?7YN|3)&&gxS  屝AkƩM%& &r#'bBky0c`)&&ȹ+|?ių?LڃeYE_QJjԵBTޏ94L.?x&9zk"UV~ČPwUO{dV_=D@dgd3{d&ǗI|@y}2SoRzy,rNr .mR1e$'m(mc^/7EuX2Jݮzd{R1ʲBU66Z TVz1,,E Page 6 of 19 SECTION 400: EVALUATION OF THE IMPACT OF AN OTC STATIN BASE: QUALIFIED RESPONDENTS Q400 First, we would like you to carefully read the following description of a new over-the-counter (non- prescription) medication to reduce cholesterol. Please read the following description carefully, as we will be asking you to give us your opinion of this product. Please read the description carefully and then click on the NEXT button to proceed. [PROGRAMMER NOTE: INSERT PRODUCT DESCRIPTION IN BLUE IN BOX WITH OUTLINE] Over-the-Counter Cholesterol-Lowering Medication The U.S. FDA (Food and Drug Administration) is currently evaluating a new non-prescription, “ over-the- counter ” medication that can help lower cholesterol, which may prevent a first heart attack. The drug being evaluated has been available for the past eighteen years as a prescription medication and, if approved, would be the first product of its kind to be available in non-prescription form. This product helps to lower LDL “ bad cholesterol, ” and increase HDL “ good cholesterol. ” This product is appropriate only for people who meet all of the following criteria:  “ Borderline ” cholesterol levels (total cholesterol 200-240)  Male aged 45 or older or female aged 55 or older  Has one of the following conditions that increase heart risk: a. Is a smoker b. Has HDL “ good ” cholesterol of 1-39 (too low) c. Has a family history of premature heart disease (heart attack or angina in father or brother before age 55 or in mother or sister before age 65) d. Has high blood pressure The drug is a small tablet that is taken once a day, preferably with an evening meal. Side effects from this product are rare and similar to those seen with sugar pill (placebo). People who have very high cholesterol (over 240), have had a stroke, heart disease (heart attack or angina), liver disease, diabetes, or who are currently taking a prescription cholesterol-lowering medication should not take this product. Also, women who are pregnant or breast-feeding should not take this product. Please consider the product you just read about when answering the following questions. BASE: QUALIFIED RESPONDENTS Q405 Based on what you have read about this product, which statement below best describes how likely you would be to use this product? Known Potential Total Risk Risk 1 Not at all likely 42 34 50 2 Somewhat likely 33 34 32 3 Likely 12 12 16 4 Very likely 8 12 3 5 Extremely likely 5 8 2 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] #xWoTU PP(P [P&@A A$FYH4Aq >@̛2~̓N-dL~={w@CZbDYhr,;d ))8rekhGXbZkAK!&ňD☄}LWfc6|ȕҮJ>j]ꯍ?/1;!I_c4߷96'<$.^dvpicQ ުosL7LPK߼W#)|*=O_D0%Y/L5LHc,׽doc' qY(|b2e>KH`x\NLwIYehMo!Qڕܤ$Jq "ڊHRm]9~"oē}N9 9EE+oQS,μX4]e ] 38Bg(hDt"S)k =䧑.l7;"my ,|"մ%׊ 8EP9kF+m~KiB>OQ~HLr*GG|S?x7Zwb7P>8IUbŖ.?aAyYbnAB{ZsM 4E+i"N5{(hb?DILyMvLUmu-XC]= _Asy5g"SVF H_#m# +9B#(ͦVUjm[#C*Ab,id!)6WY;hk}ZYY&T-2K7FA ؘ䗓>h'S^yc/UהzثA#bG#U)x9vYs<ȡh 2ry[eW?gW{bQkI>9ǥx6wHڏH> ՞#tv7f6R$<.'&ze%cNn6mV6WݕJB:S}}גj8~ot;1y'GN,?LG0/4ԛ_q&޵ bY#tΔ~ȽsL5:[S[wb&Z# C9Pd޸odO>m֒>Wj8gW3CuCalE)?jꝘʮ/`󸓵; 6F8ٝ8OK%}Ϛ dz%l([yi e]~ֱs~ ս}ݹ7h_=jT哪Wֹn p+V[A$u?n p+V[TboMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:49   ,)(16h2/K 19.~B{@x͝ _UuoBb I4_2jx*& /!&$8@L% RWA H@j@tهZ Aжڮݓ3{3&9s=|gs11EQlQ9(^ۉEqJ EEQ.~E1Xբآ ;TNTj@?gOqŒb})JUgXdݞi1>ަ؟4E~FvaoԶ>?ƃ:ҺJSR֩"ݻSk(ϸų#T(So,biqVSgִ]g}͓WmPOդqMkzӬ.W_=a֓0yߙ7LWd/na>Em^kY밫ޢg۝Bw=yؿ;}lK *4dĘ~:sjIʱmj-qu)*o]Dۥ50?`آߔVXX`~)JM1Ǐo\t޹tcf*=_1|r#LOOyO1ܗ92o3bJg:UcŲbqqeC:Nhˍb w u:-e1R~N:5cb]ǝ475kՂS 8զ%iZ,jzmbk/r˜v~ŝ6l,3礭,6X1Һ*w h-ϦWr4ݲT`b܁imnڌ-Rxm_^ATuY;iUJoW>c2-7Fbëd Qg0%_6lgѐH8idZ;ڤ 4F6:쟧Cy:: ~?џǪ1sljͻAkޮ̅S]8֩tmmL:|g#V :{J^[ vYյe쭚W1xeecۜCBs8޶x1=vt eVqF\8^K\)8αc<9sLQ<_}b_9~.bVT}պVFש.Ro]5 =VZ=KWoJ6Vj)vr r m$71nZr.l1x:cY ~ǘ8Wf%?bp<&yzἧ:G}Ta>uwWʢڜ۴mX7}]H17zd[.J'^[ޠJ# Uθط~ i9-I7m osg*RߔOK];oSM}EDi+SU@`ucF曟["jm}BCᜣÞ3(5n 5`bsEuGfKzcs_]-35囄\?vʶD칎ݵ~A?fo6@/hKnjWp[]ӡD̊|i?\">6e91ɸb~a\ u l .w6,3Spљw:_Z9D/MMPo궱t}KklQ_t6%!2OsK aѺMP$7T'>}-ŵǟ. ćC1uǔcGۣcڎE} h(WA0ѠD1GE[ hcYW|kc=.(בjqBgSxN xl<\=a[ATh7:c"7qoDү<|QjS+GUۈ L0֊3\驮s4m!>om(ܮ?sio>d0xgۋggKL;0E0˷h01р-Y֘uʰ:Xͳk75`b`d^Pc':'"':cb`zG`2WyLlLϓL*- Oh$[磯7*ge*ZrN_vZue}uנ({ 9kme)+1,1uM\NLo1f)l6cstUt&"sUhcf)L)0єDSL݀<&nDS[s'MyLlLxDSKu: GY$U0 ?il1gSshzsuן|GSbx"4f^7ږ47Yew+-|săyO=VQ"q?gW9;>m d=1|OY5}y>GHm$yLlQ)L8-cq Lb,80qcCI kn*.\krsQ`;Mp[_h S5@+ע<l`YuBW`9-5&h.y㉮Ds[hc牮Ds[DW`9-y%0љ'}ԡSkusۗeNr:W'r㚹^*]Wb˞\]_p$34V&;9iy '9aSDk' LzLlQLoL?yL)yc\آ\\01>k5(5#+[+יX|tW093zSE*yٞd$ j^u&)G<К d9,DOycbby L5ɼh L5-Y0?ɼ1"'sk[dycb`z]`2yLlLxGJ25oykos2q57ɶHks* *x"^ z*u{%|n+ ǺݥĆN)giq-zfe95L&Zآ^`E#~70Ѣ,nE0ѢDL=&D[Do`1E0yNa[}t(Ɛm[fzy9@YH:^n^ lS 5>L|ߖnI][M- uݬ2MڲBL]w4uʨKY.[Ww)ݩNc>0m}`e:kk/0Qsr|ѥDKmn㷪] mis)<6ՐN*WGLcμvMe9ev>ǂkùVrm?cwafn mm?mm}ط~~8k~_[_:{dO|Ge IYÛs=ʭ]pw'8LT'uw,w {Pۏs o&%E{Uɺ^lWn<\}E+եCl8KۜMiڃ?_.lK˶I6gl kA|%ş}!u)?>Z|آ>~X\+)YL6ﱂm>&>Pbn1cGۣcڎQ>1mP)Cu}C[$ޡ}xʿ<>WƿǑ%bmwv\ݧ2J9.=="T5=E?7_A8^0Se` z@E%^pqE{`r/cr/8Ƶ=?pqɽ`ɽ=įM{\lQUNkOhԧx'7{=?{~c8DM6^3R`&Irkd=2v񍴷dJ{I{d[spk<0&cb`™,GB` <&60[hӸ>j&w>ܛ|91_33`;ɽ(7 &.9OH{[7 &=&#\LyrL41E0=Ot&"sk6u-y|l|8%2d-9۔Ers:o^ z~ E4Fi3 =&( hcqO:L41E0Ky =&`z L41E0=Ot&"'yLlLxG#ݵ:ݭ{]Mֿ< Aw2W yH>/9V= Gd>gj85 d, =<&(hcvr&Z"&Zh-0zyLlL=<&'zyLlLx2v;tʰ8[W^#.|]9c8㾨֕{3χυ`:ՀɳE1`^ـɵ0= pLr}'_tt1K \x\>E;`r}cr}'Ƶu- }X\آ\+:tʰ4wc~;q,N18hc't9 "؀<&bz݁<&SY1\Wy\tu&.ƵYw;\DwŸ6\tq]HuU~..)"?y2S <К;6[%;6`Vh-ג`dsڑa֋`cc7?N؆cٌ!1<FU'>lQ$ZV6Yk|N_>,klDn}?e6 l$قmm1p›-y:JH&60咬/܆h15soAXp@-•!Bc+\z\lQ1+zsg&y =Upbr:i#3^uW?i%QZxf'b HyacKYN9J29[vSٮr ˥= |Xyl }2s(75 T": e[Up$3ܧU?xc4m}GDM)lZYi\DMǸՈ݂-q LJ|u:;]e:Z>Vrr宺l -ϓ@n^-{|/ݤkT^m>6֐%L|ަcгz?3oxbmn{LmD\qEz=&Zqm:|h=ŏ "G oԘ?o,ǚqoʽWt:\i =>:o*G ]x|lOq9ݲ-..so݉M?MǠs`mJhs j_T1'p}4bbn[<{0E0 '&+bRxF\֚ }ꢎ:`QC]/օӺ=ƿ0}[U?u](mlmlCyhFQl]G:_ݥW` L4ǿG3g}x1ejZv5`8_t)rc=Hyѷg#m.6ՐN3TOlʈ%1Xk=xxu] ݒ Fԛ:'_ 8z|lxke[ 2h?kzS6GVqXgXkԏ7G#lhݲ5=8(=_AU~W>^ɭ>s^wAuw \)i|N_a_  Pŏݶ }#xJ%7eeǐ)Jk\Tu%ӷ&E]ʵGǿTr#[yD'j0ھ=e[Rxc?mASXP _=&<=O$eg=&ׇA0yFcv CyFxF׵+/~ޢ1sl}\:mJՌCT4pvaw(?F+YY<lQ$~W*Z ں,7l%x&ר,wq_ߦk̛>ku=Uϼ3oQg~d\7W?\ևܳ[&׳=&׳#\4Jqj{u`߆1^/o/bǔ,/\<>~)pʉ!My|lOq9ݲ |ZY9T"ze[Jz:XD9\ƎIg#\ +/cc{0 rC|=-0 0\\bcILqmnopy\gCIZ{+UWY ,,Page 7 of 19 BASE: QUALIFIED RESPONDENTS Q415 Based on the description you just read, what, if anything, is there about this product that you think you would like? Please be specific. Known Potential Total Risk Risk Convenience (NET) 31 36 26 Efficacy (NET) 24 28 20 Safety/Side-Effects (NET) 14 19 9 Need/Criteria (NET) 12 9 14 Product Attributes (NET) 5 5 5 Overall Positive (NET) 3 3 4 Price (NET) 3 3 4 Other (NET) 8 8 8 None/Nothing 15 14 17 Don ’ t Know 1 1 1 Decline to Answer 1 1 1 BASE: QUALIFIED RESPONDENTS Q420 Based on the description you just read, what, if anything, is there about this product that you think you would not like? Please be specific. Known Potential Total Risk Risk Need/Criteria (NET) 17 18 15 Safety/Side-Effects (NET) 9 10 8 Price (NET) 4 5 3 Efficacy (NET) 2 2 2 Dosage (NET) 1 2 1 Other (NET) 17 16 18 None/Nothing 47 46 48 Don ’ t Know 3 3 4 Decline to Answer 2 2 3 BASE: QUALIFIED RESPONDENTS Q430 Based on what you have read about this product, how likely would you be to discuss this product with your doctor or another health care professional? Known Potential Total Risk Risk 1 Not at all likely 32 20 44 2 Somewhat likely 30 32 27 3 Likely 20 23 16 4 Very likely 10 13 8 5 Extremely likely 9 12 6 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] BASE: QUALIFIED RESPONDENTS Q435 Based on what you have read about this product, how likely would you be to seek out more information about this product? Known Potential Total Risk Risk 1 Not at all likely 33 24 43 2 Somewhat likely 26 26 27 xW]lUnw`[ZjH"v@l4AҴvQIcj(@O<$($$FBH0񁀯4~C1ꃉ0.wf-<899s{ZNUu)mU@ Wzn"rͯAz*1N6lUY-q e9;zF 07ħ:#8wQ%[{;z"{j-O}nc^/\=6:(b?R9Q}@#XwMbРh> uX.~w|6fv+)噥2V{jpxҕ6-*\E,N|5z#۩ߧ^@w2ze=e5Y5ʸ,e {71C{aO-(H,*(9w;!t;6U}ը ܯ&vsm\^2EWo?nqؼwGȻ׮1K>[HA}m& 9,8[sOM-y{7@_m@8|-qXsM$3r6(k(sr6<.H(G)k1n kCi.ڄ sQInr*|m?L_㤏إ:vVk2>=`؊z~|7]컃m$kQɦE hrߛyۧ|ow{s?37 /k8g-(7qsm8o֙55M|qx\qx;In: F  ]EQ=U̾(]{O3뺟Ug (7_(ˋTY\O>UWkX=t<)Q5zpL7c2Q>~~:qWXuA>}UǯNuD_/ܹ~#D}.[ ,lQ^]Ţ-r>mޣuk_lS+8ڦ+UI?0jPcu\SƵqM{NiLOQ=5%>:LFk2ggлs1_ڦ={{|.U +>kyj9 y7tׁ>u\u5[1b~_1f*ap< E/P,u" dnQ\4oo}r;Sm:6rGOsKah? w%@e8'W?CTEEڽ>yU׏ګuj~kAIp;iA΢мNoѤ_m:qձu qўTYcmu?}8wtȟm~w9s mÑ3R|€><ߦv)!_Ӝ tW~@13/0}@{aD+G0)|[1M^c?zuK^$m~?n= /WAdu{^mŌJV5>p_˕P.ɺҞ|)?,&ӪiWϝZ**jc|b9c|+yVJNTP]Qݸo؏xwb9X.$=&:6bO^>$=&'k߼D<]˕7faL^Ll|) /բK-ί=W9RqP/'=>q_ ?N,ڥonqVV(Y ;' qxb \:`J˵.I0e<.9 WV$xLr@JKre9Lr$`>IRNH=yyGgk ~tF{]4xE6Z<(F\t^~xs ;Vq9_ɟVz{7VI Nzf8?Q|_4FQ.-X= 4Gs {TIU*=9?Z*g 9㶈V5Utث_#Z<8(T|yt)utBE;I'U&WB>07B?0#ѡO[Qç^"jM ЁkS:ԠAY|xO!iQ*S[|bqN.Ȋ<uq4 mMgΆm~qC[#zCOOi~O( yVGD|@KJ%yw o"}&S}-X ^zy/EWwT%2Z^~x`6-i9**x/5W:ͯ;EZjWP[Ԝ'[@F*aQ* TW7ܫw}(WǾż|V/ۘXX }nFdGSC7Mf[T`lyɅV}\n3:AɚxLx?rv"DS~P9\6_bĻi{2^ S^X?U1၉Ϥo'}ϱ 1̉s<^jwd^^MGxXu+W j=E.{SݪUh)\|cwb ,yۦKqr;#C6a/} r0KmI~ gT<><)[22w8Gr'U]_OZ*_ޏ`'<&LtE'|m)/*O;jA2~\jaOn EC] TS3^"[sST}ӶȾ,;e /WV;d1Sdy Q<.\YwHF+dDŽ'kc[pcy=cZxrkÝ'K.}@K>ծؓB.<1`‰͢ LJ>vJ-^<G &Gz@󆿒|On˵{[n1 `y&ȞWIYۂ6\ W=Jb>4ϋ@Sh>W-_:G'oy|x9㢓GgI<ٻ̜|g oVnt@E.rmCMΠ&"^t5CdLE<&RxLEr0լ.'k`.1`jfy 7 LzLx93Ԭ.'`c,l8rC}ܽD=ZZеEUVC ts#r)jkx{@ϒy ?1_hcѡN,͟Zé Qhk}r ԾM˾Mo_mb_ AҾJr_X]OQsl՟ 2әrad"^{oӥK} }lPb> ̾Pz$]їd_6-j8lQa_+0$SwV :/4.gHbl m%|}cN~[v>RBql^XDgx9:al1d>~LOJ#gV]p{g7>mZ~S~h=KmL:]/ۅ:ؔ5]lLߜYeok/ϾAϺPms>¦ȁxi?f"6`\N,=K./~SeZ-1hQ|og ,DzNfߝ\ːMx0Yy /Q*Uܢs_"{|x#Oʖ❢3]:[gϼ,NUnjX0cEm<|\G.1edGrm&`&1`bst4LdMc,dMc&ɳq]NdMcDN&&ksh93Uc |*z|x9eݜ 7sǒxx6߇76REM͢S)O~T;`qL]%-ԏ>/pn1ɍdG<.\Yw`c˓5}w}wk9oҸVsC[b ?jẆy0^f)X>X':1>OdonA#qm{ O 1e͊f1^Ĵ$tRXݷwre1 &11ط+7xw[.1T}"7 >7D')?AR/o~þIcsƓxߍ.\ /\OTz<1`JΌY[WoI2r\'%7_凗ks>xLx9$sa&kRx~ L<&k9NN$xLx9i s0^f[36 g GfƫEE z]ƙ5% ZUs?-OwGܿUȵ]4֨Sr]&^FrYص9>kT>sD.1CMFwLjX.3MА3BKCGy燎VJG~vŏ^RDdu-x{@r Ѿ.ݤ7\>%Bguh*ٗM[Tد&{f){+Cyسc32E}ٻcN1ڳ:g/GR:0xP|Dմ޹)5$}_cތO>m{~S~h۳F_~0'~ߥ6o֞~kv(+i~lo G ɏs_oh|[}w kl\3ޟ,tsS&:cx܇s2Z=D_qc;ǽ :30mϕ]c?_r a,mu7\;6 diشG75n8?)fzч:O%G-Q'jϊlx˗Vy^{7ߘ#Il5k871ޜ/WV~Cw}x : uq3Ǟ~9uS,b|3&'5W"r)/&=&k\~ "9мk0^/ ~s`u* )_o8 " D%P}{߽?/Zh/ý_I}"~7s/-/m~\[o>0_d_F?|q bS֐1}s~`ct?ocx6~5acޙ>=o6f]dJ3}aSvN<'_^w'k=5UOeG@l=,{N.x2je.LxLx9b λ?9LJ>l-^|`ߧ,{ƑAy\A c|ltdGT^x6zI&&0`&ّ0 r'IN'INY-aTNr+7֢Kn2&q UsZ*>7'INR}r:щ{Py|x);zZSe oKo/\m=$=& KXE;re &1$=&?TYop /WVg"E ??92/N=>}??qn>'Zqo{cz<>|͢)<><ɔ#5<_ZnW3/qjaF~r^}GI0GI䈡JDž+c2?ȓuw3^++6`~@7V}с'|T!ZT$?C#˱}{]Y:E;BmSl/w1`=5z$U8̞E5<7_h''@Kľe $kc=\~Lw~oȔewE4\YDf(,,Page 8 of 19 3 Likely 18 21 15 4 Very likely 13 18 8 5 Extremely likely 10 12 7 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] BASE: QUALIFIED RESPONDENTS Q440 Based on what you have read about this product, which statement best describes how you feel about the claims made about this product? Known Potential Total Risk Risk 1 Completely unbelievable 2 1 4 2 Somewhat unbelievable 11 10 11 3 Somewhat believable 56 49 64 4 Very believable 27 37 17 5 Completely believable 4 3 5 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] BASE: QUALIFIED RESPONDENTS Q445 Based on what you have read about this product, how effective do you think this product would be at lowering your cholesterol? Known Potential Total Risk Risk 1 Not at all effective 7 5 8 2 Somewhat effective 43 41 45 3 Effective 39 37 40 4 Very effective 10 14 5 5 Extremely effective 2 3 1 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] BASE: QUALIFIED RESPONDENTS Q450 Based on what you have read about this product, how concerned are you about any side effects that might be caused by using this product? Known Potential Total Risk Risk 1 Not at all concerned 29 26 33 2 Somewhat concerned 32 37 26 3 Concerned 19 18 21 4 Very concerned 10 10 9 5 Extremely concerned 10 10 11 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH] xW_HSQΦlN]-6! siE@!MR襆AJzaD{ARQ=CXOT0)޳O]mhP j H %k~'k\t/viSB8PqG}D=QS^!JJL-wihиI d>;2|]m,j#)]d:8 ©l^/c>/9vDX -9|bΌG ,D%3=絹c[1x;{9⪹ 5x3[B_':'\k#*NѺ|Tq'`G3rG6GOZ p_M|1<`|ո8pk|?G7m&J~  ' p!=`K hC0%xCNx?B@NF{Ǔ1}Nk^Gj\·h|E##j.jb}.jQf(QG]Wsq|) 'O5:4PD9cWч㖥fE _?pF7!"Bfnj!C1X5Ѵm$ɹD9?N&3JJ:Ǽ.Nl_-cU@Bc#{Yj_{{c~grͽ)S$oX^Z\}hU:-oBSGV='cUSCT)S U`u>@NL  rMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:50  c\C G cc(16l2l/c1Di({lx ]Uyhr-I&|ICe$<PaɰJ*uu UZi WAK\K@ZMswss\Lzf}wιw:,A#ˎWx,[:U ger0,esȲCd'L秺{JΎNs-6g˳Y&ۢ,n:mO2I/*)o)`z~)VǝұQA2eUůVȶIQcvB>.^ԯXEx(˳JPKE>d;{S>E+8S;2Hif wtVx͓{)6"ϳ8}Cu>GXn=UF7jWYjS?1}G'u{ʬ "0_N*vbl7N>嫧O>۩eR7}l,/qp*nTF0jzLlQ/Nj` R:*}ej\njC 4~b?qCnWIOKwvsv7`,FCa|#mc՗Ǩ/9:EI;\K̃ LLj-|sfca{~M(z@G=I6uZ] 4Z^W"m qߥKcXc>N *|޿ԅeg+ƻڧ!os iťʻz\h:gVZǝR٠`BۥcCuݩǡq֝9ތ5ƕ>L3(֠˴Jm|tޥ!uc|?&e0룽H;>OcctQi/}V?{1փw=oO8𱧇6:&hC`Ү|ƭ;N,w?#ih3v5ٙj8xc"9jߨqpcjT!-^1nwrvlG*0w3ڜμ 8 . Ndc{@%KTy_Ol`#UϭUgr,NJ}e J o֛SoLX;0| ?i#0hM sĝvtMQPTX3w>w>(3ey֔-kXs(?^ڽFN=W+#^p… v#>_ӈꑭJ9se=Kڟv{\|S?rcC-Sv3.#7>h7;_7}j\Gn7*0nVsm¾\h7npq7{-u{q~/n^L{*yfj=qpf~zhA~`:=9C`8wf>c>08Vm'Ҿ~}Ab >k؋K SпQ{Oir|v%{ q`{m NY)(^Qy>Vj牟pm/^>¢|Y(K{\k_`~@ΰf[e;';O5XNN˸~괼zN٪볇A:WvSO[].ض6>L;_ޚ,Mn:WXKmuLYk-R\xmu&Յ\<0i'LD:wإH|c}1d MGWdy59;X߮m 5[}2_1rNy9~&,ė2(7U%86/|1w>l гuzg z3H)[<J[S;hv Ǥq4m-tݖjڪǴk=KunW u;Oפ3٨ϥYՊGttlSt]6Or19s={\[28h5n@H+&gS.˕.[U\KZsnF;nkWڅ4n;mͱ!iqε`r~ciô>, %fuqFjY|DZ(<}h9_DP)  { ()eg٤.٩k,c~OGyax :m[zV?s_C-{ԅ>ڦVGln~YѾSW+o*a%60akSo#x+";oO\Rڢ^qj֬Wjj혪:Eҵ ӯa4 Rl&Ӽ EֆF6%n[@lךݮ1E ʵZ% \G:1ę#Z+;fprH1C7[تc|<\i\G0c_Eqyb?.1.;75.m-Sumc>M~rp[7y>.mmH}Mle=ȿOeu z~rX3e|4gE| q8n/o׶)ͺp79sȷ=U`zt{+v4 NcS<Ӳ9M֔2%˰y.6-?a=C4Tig^2=<3{Y5XOl/`_cڬSeߪ{ni/TwTt[.6>[2U?nFY4[sBu늟qL-6VI#v<|5 $s-ǜ¾\ɼ2G6) @ܗϹ.^bKu 2I'pض<6αGآ.˜2yqb3/Rmn,pTF0?V ̃/ylZ> oK}˲@E!I;nxLl` :ɿ31XUbrT5\g 3j0E.|Y➥b%‚Ll=zh\7brE] ^\:t.RciXף0y1|\)jy s\-yocUsՍ<lѺ=`DkZkh3u&Zh-55pS{\ 6LlEļ[3ftvQu2- BK`Jcbk slˋukte֯=fMMW9~%]x~آu_ym|41E0O8!,0Y<&f.̩xuL1Eى{ \9-ʵ:O:1Ed{ie>W-zϠTuӽpkbXk"U`\.i㯀/Es2+h ]@|~>lyec%{x~Eղ7[tZj_cތ"oh~[y$b>b؋`Syz1s%6 ҹt+l;6.U qYk8/C:E] σ Iqam;R~NG!aRcǯm&>d'ɢO&D>LA'&=5?{ApY<.(z&kڗ-joGVy\lz&kګ!Mƕ\|2-u"qAO4>әvϒN)ӢzXB3`xLl`20W. h[n'yLf+.~L4V=.(W50њDk})x \q+zyLlu튞Ek[kv*kז2- vH' Wi<{Ll`k ~hsYv_L41 4Xw zqEz =&p]X3pѠ6 L41Ej t.آ\';S4~υWGR]?"[`{&t<'/^֚P>NwZY ӞIk>mD 6?k:en v\}|\MÿY5]߯<7(6 L!6n6\)"}?*eZv /8>2p-:N_;Q)0_KjF z!0<&60_Q/ *W`xL0# jy5\-կ7`xL֛ׅ5s8k 7xz1E)>W-ziTŧq'p{Q̉aƅu}5zpj/ul@ܢu>c_0[鷷*-LbrzLẰƿD_m<\(cbpk(=.(vi(OWiQZc50?49Zgﳁ=&{jE3pYC=.(WA0ѠD k3pѠ6 L41EmAgA-u"-LUhì}Kkm7icqkH7g"|u=~W?Uק?Rpg_hߌw.Y ;a|g`|gxČުV_tJLO= ]3Ot*6J_gv$|Ey28װ,bñf~+i98Iƛ4FWG>\ӿآ]ܵ*W{k)_L|9%>+,!_\dC` :ɟ6Z.!0Y<&Pkʗ< b:ߩs} &TE0OTۢ1]&Ty"&֝O ZbiQ- zcb&Rv=':<DgJg4N=.:r:yLtẰ+Zy\lQ^g`3"MDgE0saKgtvƉeZJ~/&[[kݳG|*p<.(׉hp2UACPbůRW>1t |-- zǧcwS-!yCA6N^|S3焷_ KnIͧ]+~4 ߅4ڼL㘽Dccq@l\Cc| "sK<&o‰zIAל2GySAo#WXEs,wgk6]#K TV&ʦ>zZ{X=݉1,e\ =!X~ڍAE]SnآziyV_X:ʿLK_u=1q%e/ &ܩt0Oԭz\lQ~ucF;dmubWV0Yw=&5cmubrE] ބma^O/Ӣz4&~&Z sl1<E}L0њDk`ڞ7ԙ[hc5=<.pEO`5-55pњEkQG}Mڗ˴.5"'0<&60 _)x~pGL#1\{p`yLl\1Uʞ=yLl`+a<.rh L1E./u"M(F+>Hx%m,-=-pnGEszH7 ΂kǼL> !>blxŽoZ]As: ?HO*aHG~\þ8<رq}@5n jSښv;/dXT3NO(x/c0w<&60P{0_Nwd1w0=vb.kZWd "\Se <&k[Ly\- 3zw^#.ibb2-a]fħu;@kܢuhc50[i-uOh3uEkQ^k`5"\h㢵pEO`5-5h㢵(viw}@iQZc50?49Zg\ L41 4z\;\D F.2: z\lD[koE[D4h>G'aZa^_,ңkH7k"|kOyr܆gf۳/ ,\ k9-9_c  aZ1E0sMUidU` LO.U*ʵZ1EmYeآ\ۥjԣkeZTKdIa]Ϣ<E&cb`~^gE{ cf.L30љDg`Wg3{fJͽ^g`3"\j}[]W}uX|RbK'~hwb݋ʴV}zJF'M!?M{~p?M{L4UyM1t34hci0[kEMGzM=&p]X'brf/ y mŊ߫ks@XZ磆Ǘ?c«ѠM)ʓ“[l)_!; IȕͫnwN%ΫϘ҇Rķ{C#EwXC|y4A̯יݮ_ldd1ʴkl`qn\mv W˨C^7OՉ|54pcofamץ@ 5w]-R:uL|K vŽP_e&B=&Btrnhl{;5br;&k _qY#ÕuLH-µ- [+mI\+zzLip=ɜ\)[Kx5nѺg`5l񋞊6[hcRZe'pњ6 L1EԼEk[k֡2(Z2- vH' L|+ } z~p? zL4f+ ܏@gy\lQ^`A#\S;=.% zLl=5 3pѠ: Ϧײ+~bʴhW5}z|l\xu>]Jaʗ?(['lf#W2-azcb3yp?yLtUyq1Y3c30[ob<.:r:yLt(/<.:rmRlbiQ_~&/Y΁:1_?V4LlLsA=Olnq=hcb`Rwg0ѳ\40[= kYpѳ:=1>_}Zշ|+Ci/e` m5t)K.]X𾭆7H'T0UA·:Cu,c6(e #5E<SU6/ʺW㴧8{o s2[8g[gof#&/| 6RUk|uE-2,RWgԴ#nrUQ>2-է)L|Hz '{CRk/ 2`zL扪_u}acb`{[0Y=&k+jd;w}5ϲXe-آ\Z&kd-p_s\B-v)zzqAK7)ZLjiX\ i㕲 7~i>8eQ2QF)ۤNN~񋒼ʳy:h#]o5~968o_3s#!sA*.\K8_UD[kL1nNEh{L^`]vTS%\u}v=.(W]0ѮDu>E[kFqA;eZT# &~ᇦ=?8G|R4hc(4hcfï`{L4̅5 &hL5՘^Pl\4qEzM=&p{݂=.(viMFeZTӌqt LlQ̽lƚ |9_-k,,XPage 9 of 19 SECTION 500: EXPLORATION OF MOTIVATIONS BASE: QUALIFIED RESPONDENTS Q500 Here is a list of phrases for your consideration. Based on what you have read, please indicate how much you agree or disagree that each statement describes this product. Please select one response for each statement. Q501 [RANDOMIZE] Agree Agree Strongly Somewhat Disagree 1 This product is effective. Total 11 79 10 Known Risk 13 79 7 Potential Risk 9 78 13 2 This is a product I am comfortable taking on a daily basis. Total 18 57 25 Known Risk 24 52 24 Potential Risk 10 63 26 3 This product is good for preventing heart disease. Total 16 66 18 Known Risk 20 64 16 Potential Risk 12 68 21 4 This product prevents borderline cholesterol from getting too high. Total 26 66 8 Known Risk 32 62 6 Potential Risk 20 70 10 5 This product will help me to make lifestyle improvements (e.g., improving diet or exercising). Total 10 51 39 Known Risk 12 49 39 Potential Risk 8 53 39 6 This product gives me control over my health. Total 16 62 22 Known Risk 20 59 21 Potential Risk 12 65 23 7 This product is not strong enough to improve my heart health. Total 3 37 59 Known Risk 5 37 58 Potential Risk 2 38 60 8 This product would be preferable to having to take a prescription drug to lower cholesterol. Total 38 47 15 Known Risk 47 42 11 Potential Risk 28 53 19 9 This product is unsafe . Total 3 28 69 Known Risk 2 27 71 Potential Risk 3 30 67 10 This product is no better than current prescription options. Total 8 55 38 Known Risk 11 55 35 Potential Risk 5 54 41 11 This product is no better than supplements or vitamins that are currently available. Total 6 37 57 Known Risk 6 32 62 Potential Risk 5 42 53 LxX[HTQ]wI(bHS$5% BM Jô{D'aEAAA}B ꣟OQG% >֞s/3s^G{r{s^{unN`,Ŵ3 `-qTrܓ}`1?qwj|>P;whd>K"iYk|{ K3H, ˆDz1=;{cg_ > ǧ]=AKڼP pGЌ߂f"ZRoC=/?3YAe9 W;n7Ggcr?K9$Ʉ!-r(Ï}I\RŨ?~yae+|w\~,$V+yf+.b)Zb: ?DY8M̧qq-Oabop?R+яhn#lFml.ÜMRֻHBE%I3^I'y;]&|V8^=m|&mD~_wʕ:$] yisө?QŴrW'_@{qiU5ߊ8ZPXk^΄+;g8%:v;g`b_Wvjt^}iwLz y@׃s)_qpppp p6***gsMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:50  Pm Q(@H(16ޡ2/^V1)F{x͝ ^Uy$C@A$*hi\Fpraq1 qBXI`Ep-VTZnCq-Z[UZVkQhC]Rls3ߜ3% ?ows)]䦔NR<'*L{Rju)5TJg4[vɔ}~^P.%sgkhN>]ºE,TkVJXCt<ȣhcyCq +uP>)뺋VaXr*meNQseOONƬ-ŽVMJRKE> ҆Gf}Wlxu[fe?M%Ct迿[f;'Ҝw3/2309 V<ۭʨ+|z&P?kG3ډ{hr_K PC!?S~M1[g|Y+Q:*7eJ V-i5 Ll`g)TL4^V[6t8d NA7k *6}{Ǿ%ZVvζ?Dc1r}-Gڛ~v//R[g3qqjOG*&ۭwq˸9*=L`3wrl6ܗV-mCm~ (L8t^[(u02tI:F> lnyԅ5(.ޖm x!yMsl=J=y$+>8dZ_v똾(wb;`[m<é#+OiN+꼳W*-Rpb "k_'Ÿ(cJucIt:fM\bO0(Q_6eئmh+*`?|koެuu@z'tz =ɵvkn#ҞTL??iOϤx6ߟ-Z7fޙɼIsPEzc?]@te"3Aέ"!/|Ɏ7i42Z[nIk3 } Э딺)]'X{kSoJ+|]s=cCmhz`gCg#a7<\kא4qsLpPҸ̃2cuL\s7ו5vS}k{G4xL\blڅ6-^h 机`oœ31(b펍.R޺fsSGl֍tc6(3VC}N|1|:g.b~ z>~k#oø1ktdyOS)'G/4/ц|K)[䱲 sK`6p 0|K'倁̙4OҙñM&O[>8YzPeoQ{\h\eާt)͏̑lLm֪w*\sH_ a^",0V LtVW5͆>QOA"-Z+ ',լ1zE[C?T`NB3n~/*ƌE&i_OU&9ll0ٲ.KϕA[sV7m?Tr?-|p?W.Q/nH;7܂X{Yl}s $Vlq'/1ݲjk{lo? mt[|˄ >`=>6ER{}G]臣sY7&py6M۞6mίhlѶ?S\}P :2Ъ}e @<8H?~.D8M763*W՚`)b~e_QhHk ju`ؿwqzj٦wqlVb;kYly^^Y'Oll5ުn]xPz|lk.l^C/?/`;0on՝>f G ;<٪y]˗ zyb?XWk^pb>笖ƹ~snk]^c):5lαY k5 oepuV.1 GÁ',*3Uآ[ƅ qTF:1W+ƞ%G2adüLloHZQ_{n?(W0*0E0 sgy8'fC/u<黥ԡ1j\}@ br}ul&׎l =آ\thz-ݣkq/Nc<&600vfeqs}f-әmn}?yآu&ZyLl*<&:`6TDg9Ye8, Lt1Ykv*66br./.)^g_-4u6FK`19Uٚ{=z53֪&71TCpiS"0Y<&kQ \"ZCO zZ5ŕEZTÒ_1y|.x5nѺ:<&ZsZy\&Zh-uY/Ek[hcץ\hbr.m~Hjm0y.A:_4&hj\4q` hcWt.آ\D F.E FNE ؋^^Z!!~Micq^|t=T) ]_˲^*jmUxT'<}OmVJCyAbmS 69?(Lv|7ߋ1ai\q9/iVn9]Glv y ۸r9,l}񦊾멌qわ:3:{Hu>HuLUvMG, _>Rd` ?mRw.˚qE5L ɚ:4kآ\_U[X{DX`>]- [" MFK(Z:Hj_ ?:<Dg9Ϊߢ%pљu&:,u0v-<.(W30љDgSO&:" aNNt֥׋ -1y}#?:{L1oY<.(W?0џDiIEEz<&`vhL 4&" aNE u={]Z?W şREXZ\&~CxU~]}ڗx|l/uwV}x1m<"7d=SӣwgKw7yuՄ33#U@:i|2Zb:k;@ҾT/hM;ąuq_iu}]뀉1Y7geu&kd Sеie آ\&kd p/2σ1-cs"\W/=0p?qE6]2O zo^O/iQ= cb@;@kܢuhc50h=<.(W50њDkhk \qEz<&Zp]\\qZtimP\/Oڊ 1yD 9TSE[ hc:\4q` hc%GhbrJ+sDch_߳XB1[zHKc~4|]2o>~oQ: Uc_1~g5wic-cV6~m7x߉XeKO_uVÿdߘ~nc Jy>2:8*?*X:s-`16|6,iOjGGз'xF s[P'qJ{ɵqM*fG5Q` cbSլ(ʗo}30Y<&koU[_dUK+U#pY<.(WVZ1Y"\;j*pY<.kUt1S =17Z<Dkt0'5Gk(W50њDkU£'pњ&Zh-µjEk[tiQR@50s<&Z`fCuhc`#A؉r zL4Ậ): z\lQ^`Ac\ۓ3pѠ: .V*3^ Am"m,={&/!|/<>~CxUm |]uzWH+<;l*r;ToBZyʾF=;yI~8Ǥq ~c㸌aacX>|N ١<:&X}@_}--{֙+qP&>dmՍHŚG>5LAPpPآ\&kd͈q=.a La`+Kׁ; '&yMAL~ՈnUiuqz&>&Q٦#<E#0љDg` <.:r:yLt:zN@K3- Lt1Ys 뗭Yh Lt1E0›.}B\_*:"N^g⅖<ؾПho&W1pџ&/µF[7;Gt.: ~{={6`0c7WAґ>Pǿ_7x_+: Z_C8nU09s|KXN>zS+-ھj{#s] T`bSլ߼x 9mIےsZ|8U{x3{\lѶ 9?uq;82{\lQ~9c2G.xVż.s|0=NŸ2{qERWk&Ŝ:k*oP@*z?H_D`xLl`( [ngzL 8\S\qo/cתQpѯ &7uh\l[tiRnQvc@50A<&Z`MCu~hcA0{n \4qEz =&p!h(WA0ѠD1=.(שh7}L寐sEXz4a27c7W7F&y|ls}d7>wxo}*{ҴUoE~3O[l1~Kٯ|Z#'1ujڂVm-Scąy?t"_գdlaNe1g{&sdSеiweآ\ &sdΎp9;`2g{L%5ߓ92gGN~2SKV7 =1GZ<QDk9FVڻ ]^YE6Ph Ly}A:{L41 i7YE Fz =&p{t.آ\D F.ю{۳3pѠ:Q }*5GࠢC }WVEy.H>]-]Zm?yadO^ Kܞ}{fRӾ=ASܒvؗ~g9{{vO4u)(¿OE{wU`?Ѧn{bm[!|%Y,,Page 10 of 19 BASE: QUALIFIED RESPONDENTS Q505 The following is a list of statements that might or might not describe the kind of people who would be appropriate candidates for this product. Thinking about the product you just read about, please indicate how much you think that each statement describes a person who would use this product. Please select a response for each statement. Q506 [RANDOMIZE] Describes Describes Does Not Very Well Somewhat Describe At All 1 Someone who has a hard time remembering to take his or her medications Total 8 37 54 Known Risk 8 37 56 Potential Risk 9 38 53 2 Someone who relies on his or her doctor to oversee his or her health Total 18 48 34 Known Risk 18 46 36 Potential Risk 18 50 33 3 Someone who is interested in preventing heart disease Total 48 46 6 Known Risk 53 41 7 Potential Risk 43 52 5 4 Someone who takes good care of himself/herself Total 30 53 17 Known Risk 31 55 14 Potential Risk 28 52 21 5 Someone who already takes a lot of medications Total 12 38 51 Known Risk 12 36 52 Potential Risk 11 40 49 6 Someone who likes to take charge of his or her health Total 43 49 9 Known Risk 48 43 8 Potential Risk 36 54 10 7 Someone who is in poor health Total 15 42 43 Known Risk 12 43 45 Potential Risk 19 41 40 8 Someone with an active lifestyle Total 21 55 24 Known Risk 24 54 22 Potential Risk 18 56 26 xWMHTQ'f5( 3kRZ6Zjf)j%V.HժZ"HȂ!nhѢEi*L}wY'={ȜpTrȥr!G_b䪱& s%X :y[O}!^wPYQz?}VnjgVyư#+ffyU>j o,hTryM"Y"Z۹.'6BQNMg\~l1fGQPko7."ƻ<D(^Bb1b3~feB7c,cT^;sѵqv1w[Ȳf6:Ś sViXa=5Q;B `Dז3PGӖ>>in=5~AWHu鞧aB|6@ hZb{{.oщNA]5:!;RK휠Lna_h*SW2\dw%}iGYcRmճYkZcvVnLjcյډ̧Z5vDqb%vDLنvԁ%lMicrosoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:50  v `fn(1622/|1X{Rx͜}WU"ȒJ)tI#E{QT6UIm\deaq?C2'Di|){Fm+K,mѶw`Ǟysoi!lV:!Ӕ(>!B`Ʌ!4- aʽOvɔ^P.] {faaaiXzÚ!dJ=a~9E \{'|JQFqTs|qDJ9Z'u.ΛI:1 VMa*? w1y_d]M! BVR>S ?>uo4MPwlYߘOǤy6[iɗ[_i[e^Ç4nE_yxkYWcvmlV}:! M<1O =]#>q.yEbڮ}l./yY 7Tk5Y=&T0),0`b1[Tsj\tпt$ۭ)byS N5}fܸ)l*[sp/kp:zmaW~n Ӕ 1m k/n&/tl1^׍+cwl7|}qy1G:֟>='W:}ϓgl4hֱ kv}|[`}xU>kΙӵ[cze陰-ܠUm~#t+uy 5Mߖ vaKm׺okENމvMQpXY[j.-{ .l`P9^6_)"\~ŹI枍 pՙiIRSPu}X?kqAO*mTڭ֏ykZX s*9-˯yɫ %W7V]lWhօCY_?b=a숧+Ə9#JcS|b$VKϗu-iZow}γ3|$7>~QtbnF`KY%\`D_O?I5<V*ݐ+Zps{8'}oΡ{9o=qX?K=6TiO6k2yZ-ZZ by8q-]!C=NmqPGߏRi42s8C=xf3g6qA q\V_Qb}Vsaɫғ@Ң)}{{|GբqQ y k#q~-?YDyzoSrU:e>_O{B~^7_Ys}Vc$}&T[+6'a.y48^gu\u n^VZxՁ~yL]ܾ"U=Ep{ԫ2kr?ܔ+sO;grFs"'0sm$˔Sk)3.[\<~΍C\<ʂ|a۵ o6[r uX\aL3ؘ3 *W5gl݀3mWʳL`֊TߕJ_,frCJ'U[#2=$&/iXXu.l_&0 `bKU[*Wօmj#ZzT Z^U{ӵiiH0i~zLl`TavʶHk~< eY֯:ޜ5`~~x3[jnu:yLt9GiDK`3-3c30S95g%pљŖ Lt1Y ׳6+Zy\l\Jg :E^&ζjNJٖJe|wok_9GkJ-r/?[jD`90џD)&LT ݦ~N1pџŖL1_בwEr,X=oujny- ;63MޛQuPo6M-*cֆ%c.[y>ͷۈxzfDt#1qOҺsk֏D7^kb"֛L1JŅ 1bDJŕw 9-tAkgXn}؃X>ה%;lsx'*ge:|oaӔsr@ٽq}VeێSqg\!is̒-u…s4݉WςB#~ zh $DUu%"Kwa06}a &60]ɟdf^ٸyRqŷ1pl oqr~LpmS4y\l\YBOK=mz/!ӐG3`CyLl`S<КԶq3%R0gP~=Ol).=$NdB LbA LXy u|]Ă},&ct%mmnظŗy\l\/_1e)\g/ G4<.T -aLl)sGO J0`f+-+tk"j3obZ9zXcbu Szty-m;{&: :woEg[*W30љDgi\}OEg[*W30љDg)e:yLtiJg :QGz*Mxme> L w;ff<&ʞ#1pџŖL1_ aߵ<.T^`?R0S4&R0G?밆n/m:z-ޫzshFW:'&5_6zzoQ-9K [47=>6lkOI8-^#+6GHoezmοiܙMۼpmYg42tړނ5|(Os#2L}}(Qpȃ_;)9}$uQ7&D GL9" h;K[\p ~7:6c_|ȫ7mاU`{yLl`*L4} "Jc/0I+۫#OT'Om߳ug>[ י%g^+z\l\*Na+1bƨA\h5:,yUz{!E`7yLl`Uav6V1<ЯԶL1/;}/z\l\~Dp/T;55~=&eO@bK:VZk9%ZQUkm+}',0<&60~hsj}\&hzQt.Rz =&LZApѠE\D p-hbK:V+.S[w]E^= K*f_ۯntO ;w4^elWܐhW@1Ry Lعay\/yG)ȣNöXKW%TZ)?;E&*i`nV3Y,,Page 11 of 19 Q506 [RANDOMIZE] Describes Describes Does Not Very Well Somewhat Describe At All 9 Someone who relies on caregivers or family members to help make decisions about his or her health Total 7 38 55 Known Risk 8 32 60 Potential Risk 7 44 49 10 Someone whose serious risk for heart disease requires consistent physician monitoring Total 20 36 43 Known Risk 16 34 50 Potential Risk 25 38 37 11 Someone who is trying to control his or her cholesterol with diet and exercise Total 42 51 8 Known Risk 47 45 8 Potential Risk 36 57 7 12 Someone with health care concerns and needs much like my own (ANCHOR) Total 25 48 27 Known Risk 33 48 20 Potential Risk 16 48 36 [PN: INSERT DEFINITION: J/US/NYC/INSERT PATH]  xUMHTQ363O7-fgI?'Nn|E%y'm7N9'p>GMbŷKf5!TBߋ53/UV J!L L3Yk`7Eto^J<0EǺKAd;tt /z2"㾰ad?9gI%GĨwc[ntқ$Oe/O.(haſ1O9g8drٲݜo7/ꛅ>/ǯ*0Microsoft Office Document Image Writer 11.03.2175.00 2004:12:13 16:07:50  $ u(1662l/1n {hx՝}y"K(KÊ؊ jAFO^*.@\YԤ&R%{m̩?HXk5Mz䘘&$@Ng~ٝ}vf {g3}ޙٵ.pRC]MJLJd ⶢ%Cκ>*8M| ^R::Z8V/aM2^?NPkll_]?-l>L_im:k оbź*me[P-u/TyGVe+婔mz;G4M㔸gwwַOѿWlV ۴oqs֏w3 [a7/6vmScq6yzTyMo!_T!9:N[5<66vg]mq,[Z۵2gJNr V-!ivs{ &60%Jeli{^k u೪v^J$Ľ6 .modK~?vS:m"yMWk}Ƣ~2뼑}e{i7VNlS |?yyk?3ӳ4w;6Wn"}_eZtԝCνރk+m$54}JTҿl{_C[ٸ.1S f|dku;4Lbrk&i>=Ot=~oNjPwž_8eo]_ӱ˟&~)w85U_Sk&ʛҤ)آ8BiȧUFAlb!.|1 '&pl$G+}g-NKK8aUrx{\鲈9_&<ڹAj,l\ !~lKNf8fD\KN J | hBQeߟ)Vuϴo@{+}1>mT-Dt.~-qSuɬ*cJG)]d\@j-ǶZK{hqm/ܦFov=^'>5.#cZ %; ~3.#cf#E pcHS21V(1Rc@p`svs?c[۽~/)>x\IzvƲ֏ʷE.O>-Qq4随=J۔Q*ff>vf̟ߣ}ټ9XwKF]_4FǕ? :fCd(\,|l,iY>?>SeK F[ 0eI{\|P2rӆKڀ-/G6S(t꠷Lfc3~]~ {I-6$[շʶTρyՑKF[UҮ7UKyVW˻ZgbPɆZ{pCn%xD}zVg_e/9\sײovcu!%~Ɩ#+Du} Lʾ^I'sKr6?L a^ļJXow٘uAk56ʲAWX[[!FW[6qOd1am۵v$V(PZ-ߏhz_`&T[6־i`$sT6N)8l߈ bKmĈ9N׌_ԽJ?՜}ʺggA@ڏo3>oPI}ra8s=;Sƾ]Cfu)kMka"5nuq ZókXaSPnm|G}v=6!9ź5 Hf3IrǺvVK_?,RU0ۡ!}{7<_[mZ}/2헝wOMcK:H5?:mk1o<#B{W4e;ڏn|]:Tu>9Mg"q͖]eƉÌQ}3u+o Rޠt߯:뿥#vdcvxJhBe>l:uzmÌph?߇,zY#xagkw޴Nq6SUݫS'|gS3oKNwuΛ|pns{:?қ1TY?' zP}0?aJ?켹;5JYW'\=jh?p>MΛ4R`PL<gR3o92\ámApl=8a%WLI[-߃mc>6^TBWGű2ШRE^piUUoJ^#pjmd{{㾒:Q:tN`ڻ\Uͫwj Ͻiy7L::9Fowa&k> Jcm m7q̜c-8`}^}}o>/oq`zTU9;T0E^?U* i7g~>Q9=_${wۼ&[:8˶8m{k{f_SD%|ocx7;9v,%@-)X[l;Sm܎O:T_6 | m?bKsime9~>JF|ί'V :8Cs;eVƸU^ݎ? ~-﷉;qO 4 ||ԗ=]c7( 6E͊eƭpvU,ߛOsJ-hmlLVEL*re=bɱs/k뢈IR031Y43cbsίE.P>ʛUMoAνۃw6۽@ߐ>c}uo\lQcVF9> }8`'_Rt7x1iS-UJS 1: 2ZVwuO+n~Z3-?}`R-9r6"潊'LmG T LE |K2OD܇h[*7"&\\/˵Yl=W~%6[*[ _!,0/Ė9Z_>פJK^u.gĹ*/(+fw֛̌MohAI.OE ~Ö拜D`.O?0џD)0Dٟ4y\l\Dpw<.K:Lu_x-Tʽ˪t)0YyLl)0m Yyƿ&*d[2}h VC\/)c-WD&F%t^\ؾ/α`;{ciiFO*i#T Qu]#GhA>Q{[ʪ|u%&ɺcbS*1n.buK*n1)es0؛g>I^0J?wU\b%rLb$pm.Yc_%z\l\+8ZjtrKcYnT0(ysQ{'__ЖJc|[Q/q-V3kڅn=>uʯYDݦ`Lt1m f&_x݂n=&S.mMEݦrzLtµd~6E[*Un?XV5=pmcbpY0@*d~oڐyo3P>u;?r!l/+,-ċ+:y)Uv]O5U@ E,uI `K=&4sWLbĖ R0X \Pgn"W%R-`K=&4+7s%^K,REWE-tkij,Kf zyzty-m~&:,7vcbK̄u&: uV\tqY*W30љDg)\t.:,pl|Ζ):;'l-cbp